Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference

Rhea-AI Summary

Avid Bioservices (NASDAQ: CDMO, CDMOP) announced its participation in the 18th Annual Morgan Stanley Global Healthcare Conference taking place from September 14-18, 2020. The company will engage in a fireside chat and one-on-one meetings on September 17 at 4:15 p.m. Eastern. This virtual conference allows stakeholders to connect remotely. A webcast of the fireside chat will be available for listening live or on-demand via Avid's investor relations page.

TUSTIN, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that the company will participate in the 18^th Annual Morgan Stanley Global Healthcare Conference.  The conference, which will take place September 14-18, 2020, is being conducted with a virtual format.

Details of the company’s participation are as follows:

• 18^th Annual Morgan Stanley Global Healthcare Conference
  Details: Avid management will participate in a fireside chat and 1-on-1 meetings
  Conference Date: September 14-18, 2020
  Fireside Chat Time/Date: 4:15 p.m. Eastern on Thursday, September 17, 2020
  Format: Virtual Conference

A webcast of the fireside chat will be made available.  To listen to the live webcast, or access the archived webcast, please visit: http://ir.avidbio.com/investor-events.

About Avid Bioservices, Inc.

Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 27 years of experience producing monoclonal antibodies and recombinant proteins, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization.  The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com.

Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401


Tim Brons (Media)
Vida Strategic Partners
415-675-7402

FAQ

When will Avid Bioservices participate in the Morgan Stanley Global Healthcare Conference?

Avid Bioservices will participate in the Morgan Stanley Global Healthcare Conference from September 14-18, 2020, with a fireside chat on September 17 at 4:15 p.m. Eastern.

How can I access the webcast of Avid Bioservices' fireside chat?

The webcast of Avid Bioservices' fireside chat can be accessed live or on-demand at their investor relations page.

What is the significance of the 18th Annual Morgan Stanley Global Healthcare Conference for Avid Bioservices?

The conference provides Avid Bioservices an opportunity to showcase its services and engage with investors in a virtual setting.

What type of organization is Avid Bioservices?

Avid Bioservices is a dedicated contract development and manufacturing organization (CDMO) focusing on biopharmaceutical drug substances derived from mammalian cell culture.